skip to Main Content
Claudia Vickers

Claudia Vickers

Chief Scientific Officer at Eden Brew, Australia

Dr. Vickers is Chief Scientific Officer at Eden Brew, an animal free dairy company. She has worked in basic and applied R&D in academia, government, research, and industry for over 20 years. From 2017-2022, she was Director of CSIRO’s Synthetic Biology Future Science Platform, a highly collaborative cross-disciplinary R&D program aimed at expanding Australia’s synthetic biology capability and building a national synthetic biology-based industry. She is co-chair of the WEF Synthetic Biology Global Future Council and is on the Executive Committee of the International Society for Isoprenoids/Terpenes. She has Adjunct Professor positions at Queensland University of Technology and Griffith University.

14:30 - 15:30

Parallel sessions

Academia session: Biotechnology - How is it shaping our future?

Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor

  • Dr. Charles Ruranga, Director of the African Centre of Excellence in Data Science, Rwanda 
  • Dr. Claudia Vickers, Chief Scientific Officer at Eden Brew, Australia
  • Kiren Naidoo, CEO of Zdravlje A.D. and Founder of Frontier Pharma, UK
  • Martin Mössler, Managing Director of Science Park Graz, Austria
  • Dr. Nataša Skoko, Head of Biotechnology Development Unit at International Centre for Genetic Engineering and Biotechnology, Italy

Business session: Accelerating innovation

Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University

  • Dan Vahdat, CEO of Huma, UK
  • Gloria Seibert, Founder & CEO at Temedica, Germany 
  • Dr. Milan Obradović, Senior Global Scientific Director Integrated Healthcare Solutions, Global Medical Affairs at Roche, Switzerland 
  • Dr. Ulrich A.K. Betz, Vice President Innovation in Merck, Germany
  • William Moss, CEO of Seven Bridges Genomics, USA

Back To Top